Healthcare provider profile · identity verified

Marta M Anghel, MD

Internal Medicine · OGDENSBURG, NY · NPI 1891855730

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	419	132
Levothyroxine Sodium	Levothyroxine Sodium	414	116
Atorvastatin Calcium	Atorvastatin Calcium	367	110
Gabapentin	Gabapentin	361	58
Losartan Potassium	Losartan Potassium	258	74
Amlodipine Besylate	Amlodipine Besylate	251	83
Metoprolol Succinate	Metoprolol Succinate	207	62
Furosemide	Furosemide	191	60
Pantoprazole Sodium	Pantoprazole Sodium	189	59
Albuterol Sulfate Hfa	Albuterol Sulfate	188	55
Potassium Chloride	Potassium Chloride	175	45
Rosuvastatin Calcium	Rosuvastatin Calcium	175	53
Simvastatin	Simvastatin	166	49
Lisinopril	Lisinopril	164	54
Hydrochlorothiazide	Hydrochlorothiazide	133	40
Pravastatin Sodium	Pravastatin Sodium	130	42
Metoprolol Tartrate	Metoprolol Tartrate	128	39
Ozempic	Semaglutide	125	21
Duloxetine Hcl	Duloxetine Hcl	109	24
Eliquis	Apixaban	109	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	106	28
Metformin Hcl Er	Metformin Hcl	102	26
Atenolol	Atenolol	97	30
Trazodone Hcl	Trazodone Hcl	97	23
Metformin Hcl	Metformin Hcl	96	35
Amitriptyline Hcl	Amitriptyline Hcl	88	17
Buspirone Hcl	Buspirone Hcl	79	18
Tramadol Hcl	Tramadol Hcl	75	23
Tamsulosin Hcl	Tamsulosin Hcl	68	18
Trulicity	Dulaglutide	61	15
Ropinirole Hcl	Ropinirole Hcl	58	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	14
Famotidine	Famotidine	55	16
Celecoxib	Celecoxib	54	14
Montelukast Sodium	Montelukast Sodium	54	15
Januvia	Sitagliptin Phosphate	52	suppressed
Alendronate Sodium	Alendronate Sodium	51	13
Meloxicam	Meloxicam	51	16
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	41
Doxycycline Hyclate	Doxycycline Hyclate	50	39
Sertraline Hcl	Sertraline Hcl	50	11
Nystatin	Nystatin	49	17
Olmesartan Medoxomil	Olmesartan Medoxomil	49	14
Hydroxyzine Hcl	Hydroxyzine Hcl	48	suppressed
Xarelto	Rivaroxaban	48	14
Glipizide Er	Glipizide	47	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	suppressed
Clopidogrel	Clopidogrel Bisulfate	46	15
Synthroid	Levothyroxine Sodium	46	13
Azithromycin	Azithromycin	45	40
Tizanidine Hcl	Tizanidine Hcl	45	suppressed
Ezetimibe	Ezetimibe	44	16
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	43	11
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Sucralfate	Sucralfate	42	suppressed
Symbicort	Budesonide/Formoterol Fumarate	42	14
Allopurinol	Allopurinol	41	13
Escitalopram Oxalate	Escitalopram Oxalate	41	13
Ondansetron Hcl	Ondansetron Hcl	39	suppressed
Farxiga	Dapagliflozin Propanediol	38	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	12
Enalapril Maleate	Enalapril Maleate	36	11
Methylprednisolone	Methylprednisolone	36	30
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	31
Baclofen	Baclofen	35	suppressed
Chlorthalidone	Chlorthalidone	35	suppressed
Ibandronate Sodium	Ibandronate Sodium	35	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	16
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	22
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Ketoconazole	Ketoconazole	31	12
Topiramate	Topiramate	31	suppressed
Glipizide	Glipizide	30	suppressed
Valacyclovir	Valacyclovir Hcl	29	14
Nystop	Nystatin	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	13
Lamotrigine	Lamotrigine	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Glimepiride	Glimepiride	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Cephalexin	Cephalexin	23	21
Verapamil Er	Verapamil Hcl	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Carvedilol	Carvedilol	22	suppressed
Finasteride	Finasteride	22	suppressed
Prednisone	Prednisone	22	14
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Varenicline Tartrate	Varenicline Tartrate	22	suppressed
Jardiance	Empagliflozin	21	suppressed
Fluconazole	Fluconazole	19	13
Mounjaro	Tirzepatide	19	suppressed
Olanzapine	Olanzapine	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Naproxen	Naproxen	17	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fosinopril Sodium	Fosinopril Sodium	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Levofloxacin	Levofloxacin	14	13
Nifedipine Er	Nifedipine	14	suppressed
Valsartan	Valsartan	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Ramipril	Ramipril	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Mesalamine Er	Mesalamine	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Ssd	Silver Sulfadiazine	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error